Cargando…
Imaging Aβ and tau in early stage Alzheimer’s disease with [(18)F]AV45 and [(18)F]AV1451
BACKGROUND: AD is a progressive neurodegenerative disorder that is associated with the accumulation of two different insoluble protein aggregates, Aβ plaques and hyperphosphorylated tau. This study aimed to investigate the optimal acquisition and quantification of [(18)F]AV45 and [(18)F]AV1451 to im...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834417/ https://www.ncbi.nlm.nih.gov/pubmed/29500717 http://dx.doi.org/10.1186/s13550-018-0371-y |
_version_ | 1783303636281982976 |
---|---|
author | Firouzian, Azadeh Whittington, Alex Searle, Graham E. Koychev, Ivan Zamboni, Giovanna Lovestone, Simon Gunn, Roger N. |
author_facet | Firouzian, Azadeh Whittington, Alex Searle, Graham E. Koychev, Ivan Zamboni, Giovanna Lovestone, Simon Gunn, Roger N. |
author_sort | Firouzian, Azadeh |
collection | PubMed |
description | BACKGROUND: AD is a progressive neurodegenerative disorder that is associated with the accumulation of two different insoluble protein aggregates, Aβ plaques and hyperphosphorylated tau. This study aimed to investigate the optimal acquisition and quantification of [(18)F]AV45 and [(18)F]AV1451 to image Aβ and tau, respectively, in subjects with AD. Fifteen subjects with early stage AD underwent a T1-weighted structural MRI and two dynamic PET scans to image Aβ (60 min, [(18)F]AV45) and tau (120 min, [(18)F]AV1451). Both dynamic BP(ND) and static SUVR outcome measures were calculated and compared for 12 out of 15 subjects who completed 60 min of the Aβ PET scan and at least 110 min of the tau PET scan. The SRTM and reference Logan graphical analysis were applied to the dynamic data to estimate regional BP(ND) values and SUVR ratios from the static data. Optimal acquisition windows were explored for both the dynamic and static acquisitions. In addition, the spatial correlation between regional Aβ and tau signals was explored. RESULTS: Both the SRTM and graphical analysis methods showed a good fit to the dynamic data for both Aβ and tau dynamic PET scans. Mean regional BP(ND) estimates became stable 30 min p.i. for [(18)F]AV45 and 80 min p.i. for [(18)F]AV1451. Time stability analysis of static SUVR data showed that the outcome measure starts to become stable for scan windows of 30–50 min p.i. for [(18)F]AV45 and 80–100 min p.i. for [(18)F]AV1451. The results from these time windows correlated well with the results from the full dynamic analysis for both tracers (R(2) = 0.74 for [(18)F]AV45 and R(2) = 0.88 for [(18)F]AV1451). There was a high correlation between amyloid uptake estimate using both dynamic analysis methods in thalamus and tau uptake in thalamus, hippocampus and amygdala. CONCLUSIONS: Short static PET scans at appropriate time windows provided SUVR values which were in reasonable agreement with BP(ND) values calculated from dynamic scans using SRTM and reference Logan. These simplified methods may be appropriate for classification and intervention studies, although caution should be employed when considering interventional studies where blood flow and extraction could change. |
format | Online Article Text |
id | pubmed-5834417 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-58344172018-03-13 Imaging Aβ and tau in early stage Alzheimer’s disease with [(18)F]AV45 and [(18)F]AV1451 Firouzian, Azadeh Whittington, Alex Searle, Graham E. Koychev, Ivan Zamboni, Giovanna Lovestone, Simon Gunn, Roger N. EJNMMI Res Original Research BACKGROUND: AD is a progressive neurodegenerative disorder that is associated with the accumulation of two different insoluble protein aggregates, Aβ plaques and hyperphosphorylated tau. This study aimed to investigate the optimal acquisition and quantification of [(18)F]AV45 and [(18)F]AV1451 to image Aβ and tau, respectively, in subjects with AD. Fifteen subjects with early stage AD underwent a T1-weighted structural MRI and two dynamic PET scans to image Aβ (60 min, [(18)F]AV45) and tau (120 min, [(18)F]AV1451). Both dynamic BP(ND) and static SUVR outcome measures were calculated and compared for 12 out of 15 subjects who completed 60 min of the Aβ PET scan and at least 110 min of the tau PET scan. The SRTM and reference Logan graphical analysis were applied to the dynamic data to estimate regional BP(ND) values and SUVR ratios from the static data. Optimal acquisition windows were explored for both the dynamic and static acquisitions. In addition, the spatial correlation between regional Aβ and tau signals was explored. RESULTS: Both the SRTM and graphical analysis methods showed a good fit to the dynamic data for both Aβ and tau dynamic PET scans. Mean regional BP(ND) estimates became stable 30 min p.i. for [(18)F]AV45 and 80 min p.i. for [(18)F]AV1451. Time stability analysis of static SUVR data showed that the outcome measure starts to become stable for scan windows of 30–50 min p.i. for [(18)F]AV45 and 80–100 min p.i. for [(18)F]AV1451. The results from these time windows correlated well with the results from the full dynamic analysis for both tracers (R(2) = 0.74 for [(18)F]AV45 and R(2) = 0.88 for [(18)F]AV1451). There was a high correlation between amyloid uptake estimate using both dynamic analysis methods in thalamus and tau uptake in thalamus, hippocampus and amygdala. CONCLUSIONS: Short static PET scans at appropriate time windows provided SUVR values which were in reasonable agreement with BP(ND) values calculated from dynamic scans using SRTM and reference Logan. These simplified methods may be appropriate for classification and intervention studies, although caution should be employed when considering interventional studies where blood flow and extraction could change. Springer Berlin Heidelberg 2018-03-02 /pmc/articles/PMC5834417/ /pubmed/29500717 http://dx.doi.org/10.1186/s13550-018-0371-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Research Firouzian, Azadeh Whittington, Alex Searle, Graham E. Koychev, Ivan Zamboni, Giovanna Lovestone, Simon Gunn, Roger N. Imaging Aβ and tau in early stage Alzheimer’s disease with [(18)F]AV45 and [(18)F]AV1451 |
title | Imaging Aβ and tau in early stage Alzheimer’s disease with [(18)F]AV45 and [(18)F]AV1451 |
title_full | Imaging Aβ and tau in early stage Alzheimer’s disease with [(18)F]AV45 and [(18)F]AV1451 |
title_fullStr | Imaging Aβ and tau in early stage Alzheimer’s disease with [(18)F]AV45 and [(18)F]AV1451 |
title_full_unstemmed | Imaging Aβ and tau in early stage Alzheimer’s disease with [(18)F]AV45 and [(18)F]AV1451 |
title_short | Imaging Aβ and tau in early stage Alzheimer’s disease with [(18)F]AV45 and [(18)F]AV1451 |
title_sort | imaging aβ and tau in early stage alzheimer’s disease with [(18)f]av45 and [(18)f]av1451 |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834417/ https://www.ncbi.nlm.nih.gov/pubmed/29500717 http://dx.doi.org/10.1186/s13550-018-0371-y |
work_keys_str_mv | AT firouzianazadeh imagingabandtauinearlystagealzheimersdiseasewith18fav45and18fav1451 AT whittingtonalex imagingabandtauinearlystagealzheimersdiseasewith18fav45and18fav1451 AT searlegrahame imagingabandtauinearlystagealzheimersdiseasewith18fav45and18fav1451 AT koychevivan imagingabandtauinearlystagealzheimersdiseasewith18fav45and18fav1451 AT zambonigiovanna imagingabandtauinearlystagealzheimersdiseasewith18fav45and18fav1451 AT lovestonesimon imagingabandtauinearlystagealzheimersdiseasewith18fav45and18fav1451 AT gunnrogern imagingabandtauinearlystagealzheimersdiseasewith18fav45and18fav1451 AT imagingabandtauinearlystagealzheimersdiseasewith18fav45and18fav1451 |